| 摘要 |
In the present invention, there is disclosed the use of a pharmaceutical composition based on eicosapentaenoic acid (EPA) containing more than 90 percent of EPA and less than 5 percent of docosahexaenoic acid (DHA) and less than 5 percent of linoleic acid; and ubiquinone in any appropriate assimilable form for the preparation of a medicament intended for the treatment of any of the following diseases or disorders: non-HodgkinÆs lymphoma; schizophrenia, schizoaffective disorders, schizotypy, depression, anxiety, bipolar disorder, mania, borderline personality disorder, alcoholism and attention deficit hyperactivity disorder or any other psychiatric illness; Parkinson's disease, Alzheimer's disease, Huntington's disease or any other "triplet repeat" disease, amyotrophic lateral sclerosis, dementia, multi-infarct dementia, multiple sclerosis, chronic fatigue and epilepsy. |
